Rowleyet al (1993)
3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting
by antagonism at the glycine site of the NMDA receptor complex. J.Med.Chem.
36 3386. Stone (2000) Development and therapeutic potential of kynurenic
acid and kynurenine derivatives for neuroprotection. TiPS 21 149.
Displays 26-fold and > 440-fold selectivity over kainate and NMDA receptors respectively. Neuro-protective; delays neuronal death in a global ischaemia model and cerebral infarction in a focal ischaemia model.